Gene · 1630
Papers3,713
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,713
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulation of core neurodevelopmental pathways-a common feature of cancers with perineural invasion. | Front Genet | 2023 | 37719704 | PubTator, text mining | PubMed |
| In silico targeting of colony-stimulating factor-1 receptor: delineating immunotherapy in cancer. | Explor Target Antitumor Ther | 2023 | 37711590 | PubTator, text mining | PubMed |
| Activation of vascular endothelial cells by synovial fibrosis promotes Netrin-1-induced sensory nerve sprouting and exacerbates pain sensitivity. | J Cell Mol Med | 2023 | 37702437 | PubTator, text mining | PubMed |
| Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer. | Jpn Dent Sci Rev | 2023 | 37680614 | PubTator, text mining | PubMed |
| Retraction Notice to: A Ligand-Gated Association between Cytoplasmic Domains of UNC5 and DCC Family Receptors Converts Netrin-Induced Growth Cone Attraction to Repulsion. | Cell | 2023 | 37669666 | PubTator, text mining | PubMed |
| A unique case of rectal cancer with coexistence of multiple pathways of carcinogenesis. | World J Surg Oncol | 2023 | 37658412 | PubTator, text mining | PubMed |
| Developing a compassionate community: a Canadian conceptual model for community capacity development. | Palliat Care Soc Pract | 2023 | 37654733 | PubTator, text mining | PubMed |
| Genetic analysis of low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma. | Breast Cancer Res Treat | 2023 | 37650999 | PubTator, text mining | PubMed |
| CT-Based Radiomics to Predict KRAS Mutation in CRC Patients Using a Machine Learning Algorithm: A Retrospective Study. | Biomedicines | 2023 | 37626641 | PubTator, text mining | PubMed |
| Changes in the Cath Lab in the Treatment of Adult Patients with Congenital Heart Disease: A 12-Year Experience in a Single Referral Center with the Establishment of a Dedicated Working Group. | J Cardiovasc Dev Dis | 2023 | 37623327 | PubTator, text mining | PubMed |
| Dendrimer-conjugated isotretinoin for controlled transdermal drug delivery. | J Nanobiotechnology | 2023 | 37605256 | PubTator, text mining | PubMed |
| Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer. | Cell Death Dis | 2023 | 37596261 | PubTator, text mining | PubMed |
| Human Retinal Ganglion Cells Respond to Evolutionarily Conserved Chemotropic Cues for Intra Retinal Guidance and Regeneration. | Stem Cells | 2023 | 37591511 | PubTator, text mining | PubMed |
| Going circular: history, present, and future of circRNAs in cancer. | Oncogene | 2023 | 37587333 | PubTator, text mining | PubMed |
| Mechanistic Study on the Degradation of Hydrolysable Core-Crosslinked Polymeric Micelles. | Langmuir | 2023 | 37581242 | PubTator, text mining | PubMed |
| Epigenetic methylation changes: implication as biomarkers in oral and maxillofacial area cancers. | Med Pharm Rep | 2023 | 37577021 | PubTator, text mining | PubMed |
| Characterization of the TRPV6 calcium channel-specific phenotype by RNA-seq in castration-resistant human prostate cancer cells. | Front Genet | 2023 | 37576552 | PubTator, text mining | PubMed |
| Adamtsl3 mediates DCC signaling to selectively promote GABAergic synapse function. | Cell Rep | 2023 | 37572323 | PubTator, text mining | PubMed |
| A Hybrid Power-Rate Management Strategy in Distributed Congestion Control for 5G-NR-V2X Sidelink Communications. | Sensors (Basel) | 2023 | 37571441 | PubTator, text mining | PubMed |
| The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease: Focusing on Molecular Mechanisms and Potential Treatment Strategies. | Int J Mol Sci | 2023 | 37569370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1630/papers?page=15